PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
Epidermal Growth Factor Receptor 24,772 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
CD68 6,424 Target Target A1AT 329 2 0.00 -1.00 0.01 0.61
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Lung Cancer 91,416 Disease Target A1AT 329 7 0.00 -0.99 0.02 0.57
Bronchitis 18,336 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.60
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Myeloperoxidase 16,181 Target Target A1AT 329 3 0.00 -1.00 0.01 0.60
Diabetes 332,602 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.51
CD4 112,219 Target Target A1AT 329 1 0.00 -1.00 0.00 0.52
Sedimentation Rate 11,455 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.60
Obesity 138,233 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.55
Ns3 3,189 Target Target A1AT 329 1 0.00 -1.00 0.00 0.61
Carcinoma 433,099 Disease Target A1AT 329 22 0.00 -0.97 0.07 0.56
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
Hemorrhage 100,979 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.54
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
CEA 17,022 Target Target A1AT 329 8 0.00 -0.99 0.02 0.62
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Cancer 1,053,491 Disease Target A1AT 329 34 0.00 -0.95 0.10 0.55
C5a 4,164 Target Target A1AT 329 1 0.00 -1.00 0.00 0.60
CCL18 256 Target Target A1AT 329 2 0.01 -0.99 0.01 0.72
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Adult Respiratory Distress Syndrome 4,034 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.62
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Chronic Obstructive Pulmonary Disease 27,780 Disease Target A1AT 329 22 0.01 -0.97 0.07 0.64
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Infection 766,637 Disease Target A1AT 329 16 0.00 -0.98 0.05 0.54
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
Bladder Cancer 21,509 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.59
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
Cathepsin G 1,613 Target Target A1AT 329 2 0.00 -1.00 0.01 0.65
Hepatitis B 57,815 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.58
Hyperbilirubinemia 5,757 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.61
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69